… has been an ambitious task due to the presence of four different dengue serotypes … the
ongoing challenges in the construction of a dengue vaccine and the current status of the vaccine …

… Finally, we emphasize the safety-related challenges associated with the risk of vaccine-…
However, a phase III trial is still ongoing and the final conclusions on efficacy, side or rare …

… of dengue vaccination, and discusses the challenges that … Finally, an ongoing clinical trial
led by WRAIR is addressing … two dengue vaccine candidates, namely the inactivated vaccine …

… severe dengue in young, vaccinated recipients. … a dengue vaccine. In this review we have
conducted a detailed overview of the DENV vaccine landscape, focusing on nine vaccines in …

… TV003/TV005 (NCT01506570) and TDV/DENVax/TAK003 (NCT02302066) are two promising
live-attenuated vaccine candidates currently ongoing in phase 3 clinical trials (39, 40). …

… are ongoing to find a better effective and accessible dengue … With all those challenges, it is
interesting to see all research … effective and accessible dengue vaccine for people needed is …

… in dengue vaccines will hopefully reduce the burden of dengue… With the ongoing threat of
COVID-19, influenza and other … face the challenge of treating patients with dengue, COVID-19, …

… vaccine research challenging. Dengvaxia, a dengue vaccine for seropositive individuals
between the ages of 9-45 has been licensed despite the significant challenges. Several other …

… However, challenges remain in developing a dengue vaccine. This includes considering …
Advances in vaccine technology, ongoing clinical trials, and the search for new platforms …

… The challenges associated with whole DENV-based vaccine strategies necessitate re-focusing
our attention toward the designed dengue vaccine … If the designed vaccines elicited …